Wolff Wiese Magana’s Niagen Bioscience NAGE Stock Holding History

Wolff Wiese Magana’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,000	Closed	-$4.59K	–	847
2023 Q1	$4.59K	Sell	3,000 -4,000	-57%	-$7.12K	﹤0.01%	435
2022 Q4	$11.8K	Hold	7,000	–	–	0.01%	317
2022 Q3	$9K	Hold	7,000	–	–	0.01%	525
2022 Q2	$12K	Hold	7,000	–	–	0.01%	512
2022 Q1	$17K	Hold	7,000	–	–	0.01%	458
2021 Q4	$26K	Hold	7,000	–	–	0.02%	386
2021 Q3	$44K	Hold	7,000	–	–	0.03%	299
2021 Q2	$69K	Hold	7,000	–	–	0.05%	239
2021 Q1	$65K	Buy	7,000 +2,000	+40%	+$15.9K	0.05%	239
2020 Q4	$24K	Buy	+5,000	New	+$24.4K	0.02%	355

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolff Wiese Magana's NAGE Position: Q2 2023 in Review

Wolff Wiese Magana sold out of Niagen Bioscience (NAGE) in Q2 2023, closing a stake of 3,000 shares — an estimated $4.59K sold.

Wolff Wiese Magana first reported a position in NAGE in Q4 2020 and held it in 10 quarters. The position peaked at $69K in Q2 2021. 55 funds tracked by Wall St. Rank hold NAGE as of Q2 2023.

Wolff Wiese Magana reported no remaining Niagen Bioscience position as of Q2 2023 after selling out during the quarter.
Wolff Wiese Magana sold 3,000 Niagen Bioscience shares in Q2 2023, an estimated $4.59K.
Wolff Wiese Magana first reported a position in Niagen Bioscience in Q4 2020 and held it in 10 quarters.
Wolff Wiese Magana's Niagen Bioscience position peaked at $69K in Q2 2021.
55 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2023.

Based on Wolff Wiese Magana's 13F filing for Q2 2023, filed 1 Aug 2023.